About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Phoenix | 176 Studies

Clinical Trials HypertensionPhoenix

Hypertension Clinical Trials in Phoenix

Find 176 clinical trials for hypertension near Phoenix, Arizona. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 176 trials

CompletedA Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)The purpose of this study is to compare the two treatment strategies; first-line combination therapy (ambrisentan and tadalafil) versus first-line monotherapy (ambrisentan or…NCT01178073·Birmingham, Alabama and 142 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedEarly Inhaled Nitric Oxide for Respiratory Failure in NewbornsThis prospective, randomized controlled trial tested whether initiating iNO therapy earlier would reduce death and reduce the use of extracorporeal membrane oxygenation (ECMO) --…NCT00005773·Birmingham, Alabama and 17 others

CompletedPulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionStudy GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial…NCT05776225·Phoenix, Arizona and 41 others

CompletedBAROSTIM NEO Hypertension Pivotal TrialThe purpose of this clinical investigation (NCT01679132) is to assess the long-term safety and efficacy of the BAROSTIM NEO System in subjects currently participating in the…NCT01679132·Phoenix, Arizona and 10 others

TerminatedThe "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 SettingA Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"NCT00467896·Phoenix, Arizona and 11 others

TerminatedStudy of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection FractionA Study of HS135 for the Treatment of in Obese Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)NCT06581159·Phoenix, Arizona and 1 other

CompletedA Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing SyndromeThis is a Phase 3, double-blind, placebo-controlled, randomized-withdrawal study to assess the efficacy, safety and pharmacokinetics (PK) of relacorilant in patients with…NCT03697109·Phoenix, Arizona and 63 others

RecruitingTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureThe purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of…NCT06526195·Phoenix, Arizona and 67 others

CompletedClinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device ImplantationSTUDY OBJECTIVES Primary objective To evaluate the effect of macitentan 10 mg on pulmonary vascular resistance (PVR) as compared to placebo in subjects with pulmonary hypertension…NCT02554903·Phoenix, Arizona and 49 others

TerminatedPRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)This is a multicenter double-blind, placebo-controlled study to evaluate the safety, efficacy and pharmacokinetics of 2 doses of CXA-10 on stable background therapy in 96 subjects…NCT03449524·Birmingham, Alabama and 45 others

CompletedA Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)Researchers are looking for other ways to treat people with PAH.NCT06664801·Phoenix, Arizona and 97 others

CompletedEfficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous PatientsThe main study purpose is to demonstrate the non-inferiority of T4032 compared to Lumigan® 0.01% in terms of efficacy.NCT05397600·Chandler, Arizona and 63 others

CompletedA Registry for Patients Taking UptraviThis is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi.NCT03278002·Mobile, Alabama and 84 others

CompletedA Study on the Long-term Efficacy of Nebivolol After Withdrawal of TherapyThis study will evaluate the long-term efficacy of nebivolol monotherapy in patients with stage 1 or stage 2 hypertension after the withdrawal of active medication.NCT00785512·Chandler, Arizona and 25 others

CompletedBardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATThis study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with pulmonary hypertension to determine the recommended dose range, evaluate the…NCT02036970·Phoenix, Arizona and 31 others

TerminatedA Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)The primary objective of this study is to demonstrate the efficacy of inhaled treprostinil compared to placebo in improving exercise ability as measured by change from baseline in…NCT03496623·Birmingham, Alabama and 75 others

CompletedClinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT InstrumentSYMPHONY is prospective, multi-center, open-label, single-arm, Phase 3b psychometric validation study of the PAH-SYMPACT, a new quality of life questionnaire for patients with…NCT01841762·Birmingham, Alabama and 80 others

CompletedDORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant HypertensionThis is a randomized, double-blind, placebo- and active-controlled study of a new experimental drug called darusentan.NCT00389779·Birmingham, Alabama and 146 others

TerminatedTo Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.To demonstrate a dose response for 1 mg, 5 mg and 20 mg TID oral sildenafil for the treatment of subjects with PAH.NCT00430716·Phoenix, Arizona and 45 others

Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionStudy ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of…NCT03683186·Phoenix, Arizona and 189 others

PreviousPage 3 of 9Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia